These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34236239)

  • 1. Computational analysis of MRIs predicts osteosarcoma chemoresponsiveness.
    Djuričić GJ; Rajković N; Milošević N; Sopta JP; Borić I; Dučić S; Apostolović M; Radulovic M
    Biomark Med; 2021 Aug; 15(12):929-940. PubMed ID: 34236239
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prediction of chemotherapy response in primary osteosarcoma using the machine learning technique on radiomic data].
    Dufau J; Bouhamama A; Leporq B; Malaureille L; Beuf O; Gouin F; Pilleul F; Marec-Berard P
    Bull Cancer; 2019 Nov; 106(11):983-999. PubMed ID: 31587802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Texture analysis for chemotherapy response evaluation in osteosarcoma using MR imaging.
    Baidya Kayal E; Kandasamy D; Khare K; Bakhshi S; Sharma R; Mehndiratta A
    NMR Biomed; 2021 Feb; 34(2):e4426. PubMed ID: 33078438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Poor Responders to Neoadjuvant Chemotherapy in Patients with Osteosarcoma: Additive Value of Diffusion-Weighted MRI including Volumetric Analysis to Standard MRI at 3T.
    Lee SK; Jee WH; Jung CK; Im SA; Chung NG; Chung YG
    PLoS One; 2020; 15(3):e0229983. PubMed ID: 32155203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can pretreatment
    Song H; Jiao Y; Wei W; Ren X; Shen C; Qiu Z; Yang Q; Wang Q; Luo QY
    Eur Radiol; 2019 Jul; 29(7):3945-3954. PubMed ID: 30859285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directionally Sensitive Fractal Radiomics Compatible With Irregularly Shaped Magnetic Resonance Tumor Regions of Interest: Association With Osteosarcoma Chemoresistance.
    Djuričić GJ; Ahammer H; Rajković S; Kovač JD; Milošević Z; Sopta JP; Radulovic M
    J Magn Reson Imaging; 2023 Jan; 57(1):248-258. PubMed ID: 35561019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the cutoff value of postchemotherapy increase in tumor volume as a predictor of subsequent oncologic events in stage IIB osteosarcoma.
    Jeon DG; Kong CB; Cho WH; Song WS; Cho SH; Choi SW; Lee SY
    J Surg Oncol; 2014 Mar; 109(3):275-9. PubMed ID: 24243222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of multi-parametric magnetic resonance imaging combined with machine learning in the assessment of necrosis of osteosarcoma after neoadjuvant chemotherapy: a preliminary study.
    Huang B; Wang J; Sun M; Chen X; Xu D; Li ZP; Ma J; Feng ST; Gao Z
    BMC Cancer; 2020 Apr; 20(1):322. PubMed ID: 32293344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Histologic Neoadjuvant Chemotherapy Response in Osteosarcoma Using Pretherapeutic MRI Radiomics.
    Bouhamama A; Leporq B; Khaled W; Nemeth A; Brahmi M; Dufau J; Marec-Bérard P; Drapé JL; Gouin F; Bertrand-Vasseur A; Blay JY; Beuf O; Pilleul F
    Radiol Imaging Cancer; 2022 Sep; 4(5):e210107. PubMed ID: 36178349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Prediction of Breast Cancer Therapy Response using Multiresolution Fractal Analysis of DCE-MRI Parametric Maps.
    Machireddy A; Thibault G; Tudorica A; Afzal A; Mishal M; Kemmer K; Naik A; Troxell M; Goranson E; Oh K; Roy N; Jafarian N; Holtorf M; Huang W; Song X
    Tomography; 2019 Mar; 5(1):90-98. PubMed ID: 30854446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro drug sensitivity (IDS) of patient-derived primary osteosarcoma cells as an early predictor of the clinical outcomes of osteosarcoma patients.
    Klangjorhor J; Phanphaisarn A; Teeyakasem P; Chaiyawat P; Phinyo P; Settakorn J; Theera-Umpon N; Pruksakorn D
    Cancer Chemother Pharmacol; 2020 Jun; 85(6):1165-1176. PubMed ID: 32476109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging is appropriate for determining the osteotomy plane for appendicular osteosarcoma after neoadjuvant chemotherapy.
    Han G; Wang Y; Bi WZ; Wang DJ; Lu SB; Zhang L; Zhao B
    Med Oncol; 2012 Jun; 29(2):1347-53. PubMed ID: 21350876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of chemotherapy response by PET-CT in osteosarcoma: correlation with histologic necrosis.
    Bajpai J; Kumar R; Sreenivas V; Sharma MC; Khan SA; Rastogi S; Malhotra A; Gamnagatti S; Kumar R; Safaya R; Bakhshi S
    J Pediatr Hematol Oncol; 2011 Oct; 33(7):e271-8. PubMed ID: 22193290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractal and Gray Level Cooccurrence Matrix Computational Analysis of Primary Osteosarcoma Magnetic Resonance Images Predicts the Chemotherapy Response.
    Djuričić GJ; Radulovic M; Sopta JP; Nikitović M; Milošević NT
    Front Oncol; 2017; 7():246. PubMed ID: 29098142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and external validation of an MRI-based radiomics nomogram for pretreatment prediction for early relapse in osteosarcoma: A retrospective multicenter study.
    Chen H; Liu J; Cheng Z; Lu X; Wang X; Lu M; Li S; Xiang Z; Zhou Q; Liu Z; Zhao Y
    Eur J Radiol; 2020 Aug; 129():109066. PubMed ID: 32502729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of chemotherapy response in osteosarcoma with FDG-PET.
    Hamada K; Tomita Y; Inoue A; Fujimoto T; Hashimoto N; Myoui A; Yoshikawa H; Hatazawa J
    Ann Nucl Med; 2009 Jan; 23(1):89-95. PubMed ID: 19205843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Delta-radiomics model for preoperative evaluation of Neoadjuvant chemotherapy response in high-grade osteosarcoma.
    Lin P; Yang PF; Chen S; Shao YY; Xu L; Wu Y; Teng W; Zhou XZ; Li BH; Luo C; Xu LM; Huang M; Niu TY; Ye ZM
    Cancer Imaging; 2020 Jan; 20(1):7. PubMed ID: 31937372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour response of osteosarcoma to neoadjuvant chemotherapy evaluated by magnetic resonance imaging as prognostic factor for outcome.
    Laux CJ; Berzaczy G; Weber M; Lang S; Dominkus M; Windhager R; Nöbauer-Huhmann IM; Funovics PT
    Int Orthop; 2015 Jan; 39(1):97-104. PubMed ID: 25432323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of response to neoadjuvant chemotherapy in osteosarcoma using dynamic contrast-enhanced MRI: development and external validation of a model.
    Kalisvaart GM; Van Den Berghe T; Grootjans W; Lejoly M; Huysse WCJ; Bovée JVMG; Creytens D; Gelderblom H; Speetjens FM; Lapeire L; van de Sande MAJ; Sys G; de Geus-Oei LF; Verstraete KL; Bloem JL
    Skeletal Radiol; 2024 Feb; 53(2):319-328. PubMed ID: 37464020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI-based radiomics signature for pretreatment prediction of pathological response to neoadjuvant chemotherapy in osteosarcoma: a multicenter study.
    Chen H; Zhang X; Wang X; Quan X; Deng Y; Lu M; Wei Q; Ye Q; Zhou Q; Xiang Z; Liang C; Yang W; Zhao Y
    Eur Radiol; 2021 Oct; 31(10):7913-7924. PubMed ID: 33825032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.